Pharmaust Ltd - ESG Rating & Company Profile powered by AI
The ESG score covers 17 United Nations SDGs including: 'Zero Hunger', 'Reduced Inequalities' and 'Partnerships for the Goals'. This ESG assessment for Pharmaust Ltd represents its reporting of the UN Sustainable Development Goals. This webpage of Pharmaust Ltd is prepared by All Street Sevva using proprietary Cognitive Robots.
Pharmaust Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.6; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.7.
7.6
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 187 | Richter Gedeon Vegyeszeti Gyar Nyrt | 7.7 | High |
| 187 | Vitrolife AB | 7.7 | High |
| 209 | Pharmaust Ltd | 7.6 | High |
| 209 | Actinogen Medical Ltd | 7.6 | High |
| 209 | Bajaj Healthcare Ltd | 7.6 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Pharmaust Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Pharmaust Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Pharmaust Ltd report the average age of the workforce?
Sign up for free to unlockDoes Pharmaust Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Pharmaust Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Pharmaust Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Pharmaust Ltd offer flexible work?
Sign up for free to unlockDoes Pharmaust Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Pharmaust Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Pharmaust Ltd conduct supply chain audits?
Sign up for free to unlockDoes Pharmaust Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Pharmaust Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Pharmaust Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Pharmaust Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Pharmaust Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Pharmaust Ltd disclose water use targets?
Sign up for free to unlockDoes Pharmaust Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Pharmaust Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Pharmaust Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Pharmaust Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Pharmaust Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Pharmaust Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Pharmaust Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Pharmaust Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Pharmaust Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Pharmaust Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Pharmaust Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Pharmaust Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Pharmaust Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Pharmaust Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Pharmaust Ltd disclose its waste policy?
Sign up for free to unlockDoes Pharmaust Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Pharmaust Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Pharmaust Ltd disclose energy use targets?
Sign up for free to unlockDoes Pharmaust Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Pharmaust Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Pharmaust Ltd
These potential risks are based on the size, segment and geographies of the company.
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.